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Introduction: One of the most common sleep disorders, insomnia is a significant public
health concern. Several psychiatric disorders, such as anxiety disorders and depression,
have shown strong relationships with insomnia. However, the clinical impact of the
combination of these two conditions on insomnia severity and sleep quality remains
unknown. We investigated the relationship between sleep disturbance and psychiatric
comorbidities in subjects with high risk for insomnia.
Methods: We analyzed data from a nation-wide cross-sectional survey of Korean
adults aged 19 ∼ 69 years conducted from November 2011 to January 2012. The
survey was performed via face-to-face interviews using a structured questionnaire. We
used the insomnia severity index (ISI) to evaluate insomnia and defined respondents
with ISI scores of ≥10 were considered to be at high risk for insomnia. To diagnose
anxiety and depression, we used the Goldberg anxiety scale (GAS) and Patient Health
Questionnaire-9 (PHQ-9), respectively.
Results: Of the 2,762 respondents, 290 (10.5%) were classified as subjects with high
risk for insomnia; anxiety [odds ratio (OR), 9.8; 95% confidence interval (CI), 7.3–13.1]
and depression (OR, 19.7; 95% CI, 13.1–29.6) were more common in this population
than in participants without insomnia. Of the participants with insomnia, 152 (52.4%)
had neither anxiety nor depression, 63 (21.7%) only had anxiety, 21 (7.2%) only had
depression, and 54 (18.6%) had both anxiety and depression. The group with both
anxiety and depression was associated with worse scores on sleep-related scales than
the other groups [high ISI, Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleepiness
Scale]. The relationship between outcome measures (ISI and PSQI) and psychiatric
problems was significant only when anxiety and depression were present. The PSQI
has a significant mediation effect on the relationship between psychiatric comorbidities
and insomnia severity.
Oh et al. Insomnia and Psychiatric Morbidities
Conclusion: Among the respondents with insomnia, psychiatric comorbidities may
have a negative impact on daytime alertness, general sleep quality, and insomnia severity,
especially when the two conditions are present at the same time. Clinicians should,
therefore, consider psychiatric comorbidities when treating insomnia.
Keywords: insomnia, mood disorder, depression, anxiety, sleep quality
INTRODUCTION
As one of the most common sleep disorders, insomnia has
become a significant public health problem.While the prevalence
of insomnia varies considerably across countries, its global
prevalence of insomnia as defined by the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-
IV) criteria is estimated to be∼6–10% (1–3).
Insomnia reportedly increases the rate of car accidents
(4), decreases job performance, results in self-medication with
alcohol as well as socio-economic problems (5–7), and has been
associated with the onset of cardiovascular diseases (8).
Although a previous (second) edition of the International
Classification of Sleep Disorders (ICSD-2) distinguished
psychophysiological insomnia from mental-illness induced
insomnia (9), there are substantial overlap features between the
two: e.g., conditioned arousal, poor sleep hygiene, and excessive
worry about sleep (10). Also, many subjects with insomnia
have psychiatric comorbidities, rendering the discrimination of
insomnia subtypes difficult. Because of these issues (overlapping
primary and secondary insomnia), in the next version, ICSD-3,
insomnia was recategorized according to time course (10).
Nevertheless, it is still of great value to recognize the most
common psychiatric comorbidities such as anxiety disorders
and depression in patients with insomnia (11). Among patients
with insomnia, the prevalence of anxiety disorder, including
generalized anxiety disorder, panic disorder, post-traumatic
stress disorder, and phobia, is 24–36% (11, 12), while that of
major depression is 14–31% (11, 12). Conversely, about 90% of
patients with depression complain of sleep disturbance (13, 14).
Similarly, sleep problems are much more common among
individuals with anxiety disorders (15, 16).
Multiple studies have investigated the relationship between
sleep disorders and psychiatric comorbidity. A study that used
data collected by the national survey in the United States revealed
that individuals with any comorbid sleep problem (especially
non-restorative sleep) are more prone to impairments of daytime
activities (17). Using data obtained by the same survey, another
investigation reported that the rate of insomnia complaints was
highest among individuals with anxiety and mood disorders
(42–63%) (18). However, to date, it remains unclear whether
the combination of anxiety and mood (depression) problems
aggravate the severity of insomnia itself and the sleep quality of
people at high risk for insomnia.
This study explored the relationships among insomnia
severity, sleep quality and daytime sleepiness, and comorbidities
with anxiety and depression among individuals at high risk for
insomnia. In addition, we used mediation modeling to evaluate
whether insomnia severity is mediated by changes in general
sleep quality.
METHODS
Survey Procedure
We used data from a nationwide, cross-sectional survey
of headache and anxiety in the general Korean population
conducted from November 2011 to January 2012 (19). Trained
interviewers performed structured, face-to-face interviews that
included questionnaires regarding sleep and headache disorders
and mood problems (anxiety and depression). Adults between
the ages of 19 and 69 years were included. Besides, we collected
the respondents’ demographic and geographic information. The
target area, sampling method, and detailed survey procedures
were same as the previously documented process (19). The
distribution in this study and the total population were not
significantly different in sex, age groups, size of a residential area,
and educational level.
Diagnosis of Insomnia, Anxiety, and
Depression
We used the insomnia severity index (ISI) to define high risk
for insomnia. Subjects who received an ISI score of ≥10 were
classified as high risk for insomnia according to a previous
community-based study (20). Using an ISI score of 10 as the
cutoff, insomnia was detected with 86.1% sensitivity and 87.7%
specificity (20).
For the diagnosis of anxiety and depression, we used the
Goldberg anxiety scale (GAS) and Patient Health Questionnaire-
9 (PHQ-9), respectively. The GAS consists of four screening and
five supplementary questions. The validated Korean version of
the GAS features a sensitivity of 82.0% and a specificity of 94.4%
(21). At least two positive answers to screening and five or more
positive answers to complementary questions in GAS questions
indicated anxiety. The PHQ-9 was used to diagnose depression
(22). The Korean version of the PHQ-9 features 81% sensitivity
and 89.9% specificity (23). Participants with a PHQ-9 score
of ≥10 were considered to have depression. We classified the
respondents into four groups: individuals (1) without anxiety or
depression, (2) with anxiety but without depression, (3) without
anxiety but with depression, and (4) with both anxiety and
depression. The demographic data of the participants are shown
in Table 1.
Measures Related to Sleep Quality
Each individual was asked to complete questionnaires, including
the Pittsburgh Sleep Quality Index (PSQI), which accesses
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TABLE 1 | Sociodemographic distribution of all survey participants, the total
Korean population, and of cases identified as insomnia, anxiety, and depression.
Insomnia
(n = 290)
P Anxiety
(n = 268)
P Depression,
(n = 116)
P
Gender <0.01 <0.01 <0.01
Male (1,345) 117 (8.7%) 109 (8.1%) 43 (3.2%)
Female (1,350) 173 (12.8%) 159 (11.8%) 73 (5.4%)
Age 0.53 0.71 0.75
19–29 (542) 59 (10.9%) 53 (9.8%) 23 (4.2%)
30–39 (604) 53 (8.8%) 51 (8.4%) 32 (5.3%)
40–49 (611) 66 (10.8%) 67 (11.0%) 24 (3.9%)
50–59 (529) 63 (11.9%) 53 (10.0%) 22 (4.2%)
60–69 (409) 49 (12.0%) 44 (10.8%) 15 (3.7%)
Size of residential area 0.95 0.71 0.76
Large city (1,248) 136 (10.9%) 130 (10.4%) 57 (4.6%)
Medium-to-small city
(1,186)
125 (10.5%) 112 (9.4%) 47 (4.0%)
Rural are (261) 29 (11.1%) 26 (10.0%) 12 (4.6%)
Educational level* <0.01 0.03 0.70
Middle school or
less (393)
62 (15.8%) 55 (14.0%) 20 (5.1%)
High school (1,208) 116 (9.6%) 111 (9.2%) 49 (4.1%)
College or more
(1,068)
109 (10.2%) 100 (9.4%) 47 (4.4%)
Type of job** 0.58 0.57 0.32
Shift work (145) 18 (12.4%) 17 (11.7%) 9 (6.2%)
Regular work (2,157) 224 (10.4%) 209 (9.7%) 87 (4.0%)
Total subjects: 2,695; P, p-value; *non-responder: 26; **non-responder: 393.
the multifactorial construct of sleep dysfunction with strong
reliability and validity (24), and the Epworth Sleepiness Scale
(ESS). which assesses each participant’s daytime sleepiness
(25). The subjective and objective sleep qualities measured
with ISI feature a high concordance with daytime disability
(26). Even young adults with insomnia frequently complain of
daytime sleepiness (27). Additionally, each subject’s ISI score was
categorized into one of three groups (mild insomnia, 10 ≤ ISI <
15; moderate, 15 ≤ ISI < 20; severe, ISI > 20).
Ethics
This study was approved by the institutional review board/ethics
committee of the Severance Hospital, and written informed
consent was obtained from each participant.
Statistical Analysis
We used the chi-square test to examine whether the number
of diagnoses differed according to sex, age, size of a residential
area, educational level, and types of work shift. We compared
group differences in sleep time and ESS and PSQI scores
using the Kruskal-Wallis test followed by Bonferroni’s
multiple comparison correction. Group differences in ISI
severity and insomnia characteristics were compared with
Jonckheere’s trend test. Univariate and multivariate logistic
regression analysis was performed to evaluate the odds ratio
(OR) of anxiety and depression in individuals with high
risk for insomnia compared to those without high risk for
insomnia. The same procedure was used to compare the
PSQI and ISI scores stratified by the presence of depression
or anxiety between groups; sex, age group, size of residential
area, and education level were included in the multivariate
analysis. To examine whether the association between
anxiety and depression comorbidities and insomnia risk
is mediated by sleep quality, we performed a mediation
analysis based on a previously developed method (28). In all
the statistical analyses, two-tailed p < 0.05 were considered
statistically significant.
RESULTS
Demographic Data of the Subjects
Of the total 7,430 interviewees, 3,114 completed the survey
(acceptance rate of 41.9%), and 352 subjects suspended the
interview. The final sample that completed the survey and
the interview included 2,762 individuals (19). The enrollment
flow chart of this study is presented in Figure 1. The
prevalence of insomnia, anxiety, and depression according
to sex, age distribution, size of the residential area, and
education level is depicted in Table 1. Insomnia, depression,
and anxiety were significantly more prevalent among women.
Participants with the lowest educational levels were associated
with a higher prevalence of insomnia and anxiety than
were those who had completed high school, college, or
graduate school.
Prevalence of Insomnia, Anxiety, and
Depression and Mean Scores on
Sleep-Related Scales
Of the 2,762 participants, 290 (10.5%) were classified as having
a high risk for insomnia. The frequencies of insomnia, anxiety,
and depression are presented in Table 1 according to sex, age
group, size of the residential area, and education level. The
mean ISI, ESS, and PSQI scores of individuals with high risk
for insomnia were 14.37 ± 4.39, 7.73 ± 4.87, and 7.42 ± 2.59,
respectively. Of the 290 subjects with high risk for insomnia,
152 (52.4%) had neither anxiety nor depression (Group 1), 63
(21.7 %) had anxiety only (Group 2), 21 (7.2%) had depression
only (Group 3), and 54 (18.6%) had both anxiety and depression
(Group 4). Anxiety was more common among individuals who
had a high risk for insomnia than among those who did not
[40.3% vs. 6.1%; OR, 10.1; 95% confidence interval (CI), 7.6–
13.4]; this finding remained consistent after adjustment for
demographic variables (OR, 9.8; 95% CI, 7.3–13.1). Depression
was also more common among individuals who had a high
risk for insomnia than those who did not (25.9% vs. 1.7%; OR,
20.1; 95% CI, 13.4–30.2); this finding also remained consistent
after adjustment for demographic variables (OR, 19.7l 95% CI,
13.1–29.6) (Table 2).
Difference in Sleep-Related Scales Among
the Four Groups
Participants at high risk for insomnia with both anxiety and
depression were associated with significantly higher ESS and
PSQI scores relative to the anxiety-only group (Figure 2).
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FIGURE 1 | Flow chart of participants in the Korean Headache-Sleep study. Whether individuals had anxiety (A) or depression (D) are denoted by positive (+) and
negative (–). A–/D–, without anxiety or depression; A+/D–, with anxiety only; A–/D+, with depression only; A+/D+, with both anxiety and depression.
Meanwhile, individuals with no psychiatric comorbidities were
associated with lower PSQI scores relative to the three other
groups. ISI scores were significantly higher among participants
with both anxiety and depression than those with any
psychiatric comorbidities. When stratified by the presence of
anxiety and depression, severe ISI tended to increase from
Groups 1–4 (Figure 3).
Insomnia Characteristics According to the
Presence of Anxiety or Depression
No statistical differences were observed among the 4 groups in
average sleep time during workdays, weekends, and overall sleep.
The three insomnia-related symptom scales of each group are
presented in Figure 3. Regarding the difficulty in initiating sleep
and feelings of impaired quality of life, only Groups 1 and 4
featured a statistically significant difference. Group 4 was more
likely to have difficulties in maintaining sleep than were Groups
1 and 2. The groups did not differ in their scores on the frequent
awakening scale.
Mediation Model Analysis
When insomnia was comorbid with both anxiety and depression,
PSQI and ISI were significantly correlated with each other
(Tables 3, 4). The relationship between anxiety and ISI (beta
= 4.21) was attenuated when PSQI was used as a mediator
(Figure 4). The Sobel test revealed the significance of the indirect
effect of PSQI in mediating both anxiety and depression and
ISI (Table 5).
DISCUSSION
We found the prevalence of high risk for insomnia in the Korean
adult population to be 10.5%, which is significantly different from
previously reported rates in the Korean population (about 20%).
Differences between the methodology of our study and those of
previous investigations, which used telephone-based interviews
without validated questionnaires, may account for the divergent
findings (29, 30). Measuring residential noise levels in addition to
employing a structured questionnaire, a population-based study
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TABLE 2 | Logistic regression analysis.
Insomnia,
n = 290
Non-insomnia,
n = 2,472
Univariate analysis Multivariate analysis¶
OR CI OR CI
Anxiety 117 (40.3%) 151 (6.1%) 10.1 7.6–13.4 9.8 7.3–13.1
Depression 75 (25.9%) 41 (1.7%) 20.1 13.4–30.2 19.71 13.1–29.6
Insomnia vs. non-insomnia population. OR, odds ratio; CI, 95% confidence interval; ¶adjusted for age, gender, education level, and size of residential area.
FIGURE 2 | Differences in scores on sleep-related scale across four groups. (A) Epworth sleepiness scale and (B) Pittsburg sleep quality index is depicted in box
plots. (C) Proportion of each insomnia severity index category is shown in a stacked bar plot. A–/D–, without anxiety or depression; A+/D–, with anxiety only; A–/D+,
with depression only; A+/D+, with both anxiety and depression; *p < 0.05, **p < 0.01, and ***p < 0.001.
conducted in Japan, reported a crude prevalence of insomnia of
8.8% (31), which better accords with our results. The prevalence
of overall anxiety and depression observed in our study was also
similar to or slightly higher than the rates reported by prior
Korean epidemiologic studies (32, 33). Similar to a previous study
(34), we found that the prevalence of insomnia to be higher
among women and individuals with low levels of education. We
also found no association between age and the prevalence of
insomnia. This discrepancy may be due to the changes in the
lifestyles of young Korean adults, which might cause higher rates
of insomnia among adults below the age of 30 (35).
We observed that 47.6% of individuals with high risks for
insomnia had comorbidities of anxiety or depression. This
finding in the Korean population was similar to a previously
reported rate: 40% of individuals with insomnia had comorbid
psychiatric disorders (11), among which depression and anxiety
disorders were reportedly the most common.
As expected, Group 1 had lower PSQI and ISI scores than
those with anxiety-only, depression-only, or both (Groups 2,
3, and 4). The ESS scores of subjects with anxiety-only or
depression-only (Groups 2 and 3), but not both (Group 4), did
not differ significantly from those of individuals without any
anxiety or depression (Group 1) as depicted in Figure 1. This
might be due to individuals with insomnia having excessive
hyperarousal continuing throughout the day time rather than
daytime sleepiness. Group 4 was consistently associated with
poorer sleep-related indices than was Group 2. While Groups 3
and 4 differed significantly in the proportion of participants who
had higher ISI scores (Figure 3C), they did not differ significantly
in ESS and PSQI scores. This result might be due to a lack
of statistical power associated with sample sizes (Group 3 was
relatively small).
Individuals with high risk for insomnia are associated with an
increased incidence of anxiety and depression relative to those
without insomnia. After controlling for possible confounding
variables, subjects with insomnia were found to be 9.8 times
more likely to have anxiety than subjects without insomnia and
19.7 times more likely to have depression. In addition, we found
Groups 2, 3, and 4, in order, had significantly higher rates of
insomnia symptoms.
Numerous studies have reported an association between
insomnia and depression and anxiety (36–40). Indeed,
patients with persistent insomnia are reportedly predisposed
to developing psychiatric illness and are more prone to the
recurrence of depression (41, 42). Among patients with
partially treated depression, residual symptoms such as anxiety
and insomnia are among the most powerful predictors for
relapse (41). Additionally, insomnia and anxiety share a
pathogenetic mechanism: hyperarousal caused by dysregulation
of neurotransmitter systems including cholinergic and GABA
(gamma-aminobutyric acid) eric mechanisms (43). Hyperarousal
and insufficient sleep disrupt the function of corticolimbic
circuitry, which leads to impaired affective reactivity and
regulation (44). Genetic studies also showed a strong overlap
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FIGURE 3 | Stacked bar plot showing the proportion of each insomnia characteristic scale 1–5 across groups. A–/D–, without anxiety or depression; A+/D–, with
anxiety only; A–/D+, with depression only; A+/D+, with both anxiety and depression. Insomnia characteristic scale (ICS) was graded on a scale of 1–5.
TABLE 3 | Mediation analysis.
Variables Beta SE P
Outcome Predictors
ISI PSQI 0.50 0.08 <0.0001
ISI Both anxiety and depression 0.21 0.56 <0.0001
PSQI Both anxiety and depression 0.33 0.37 <0.0001
Indirect effect 0.17 0.36 <0.0001
Total effect 0.37 0.61 <0.0001
ISI, insomnia severity index; PSQI, Pittsburgh Sleep Quality Index; SE, standard error;
P, p-value.
TABLE 4 | Linear regression analysis, endpoint: ISI.
Univariate
analysis
Beta SE P Multivariate
analysis¶
Beta SE P
Anxiety only 0.2 0.6 0.70 Anxiety only 0.2 0.6 0.75
Depression
only
0.8 1.0 0.40 Depression
only
1.0 1.0 0.30
only one of
anxiety or
depression
0.5 0.6 0.41 Only one of
anxiety or
depression
0.5 0.6 0.38
Anxiety +
Depression
4.2 0.6 <0.0001 Anxiety +
Depression
4.1 0.6 <0.0001
ISI, insomnia severity index; ¶adjusted for age, gender, education level, and size of
residential area; SE, standard error; P, p-value.
between genetic influences on insomnia, depression, and anxiety
(44). This is reflected in high comorbidity of the two conditions
(70–90% of patients with anxiety report insomnia) (45).
The mediational model revealed that the effect of combined
anxiety and depression on insomnia severity is mediated by
poor sleep behaviors. Considering that the essential feature
of insomnia is conditioned arousal affected by dysfunctional
efforts to sleep and negative expectations, patients with insomnia
FIGURE 4 | Mediation model: the indirect effect of combined anxiety and
depression on ISI scores through PSQI. Unstandardized regression
coefficients are presented for each path ***p < 0.001.
become anxious and frustrated as insomnia symptoms persist.
The mediator PSQI covers general sleep problems including
sleep latency; sleep duration and efficiency; and sleep-disturbing
factors, such as nocturia, nocturnal breathing problems, pain,
feeling too hot or cold, use of sleeping pills, and daytime
dysfunction. Even in the absence of direct insomnia-related
factors, nearly all of these components are associated with
somatic symptoms of depression (46), and more than half of
patients with anxiety disorders report those somatic complaints
(47). These observations are in agreement with the findings of
our mediation analysis: depression and anxiety have indirect
relationships with the degree of insomnia severity and poor
sleep-related somatic symptoms, which in turn aggravates
insomnia severity.
There was a systemic review on the relationships among
anxiety, depression, and sleep disturbance. They showed
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TABLE 5 | Linear regression analysis, endpoint: PSQI.
Univariate
analysis
Beta SE P Multivariate
analysis¶
Beta SE P
Anxiety only 0.1 0.4 0.85 Anxiety only 0.1 0.4 0.86
Depression
only
0.9 0.6 0.11 Depression
only
1.0 0.6 0.10
Only one of
anxiety or
depression
0.4 0.3 0.28 Only one of
anxiety or
depression
0.4 0.3 0.27
Anxiety +
Depression
4.1 0.3 <0.0001 Anxiety +
Depression
2.2 0.4 <0.0001
PSQI, Pittsburgh Sleep Quality Index; ¶adjusted for age, gender, education level, and size
of residential area; SE, standard error, P, p-value.
that insomnia and sleep quality features have “bidirectional”
relationships with anxiety and depression, respectively (48).
Moreover, regarding treatment, cognitive behavioral therapy
that focuses on attenuating anxiety and depression reduces
insomnia severity and the symptoms of the two psychiatric
conditions (49).
Our study is subject to several limitations. First, we did not
consider comorbidities of anxiety and depression with other
sleep disorders, including obstructive sleep apnea, narcolepsy,
and restless legs syndrome. The presence of any pain or other
significant medical illnesses was also not investigated. Second,
even though we performed a population-based study with a
low sampling error, the statistical power for the examination of
subgroups might have been diminished due to the small samples
(especially Group 3). Third, in the mediation analysis, we did not
conduct a detailed investigation to elucidate the component of
PSQI that features a close relationship with insomnia severity.
Third, we did not analyze longitudinal data which causes a
problem to establish causality, despite a quite large sample.
Last, we didn’t consider the impact of medication use when we
analyzed our data. The medication status is an important factor
that can change the subjects’ mental status. Unfortunately, our
research target was the general population. So, it was not easy to
obtain optimal medical information from the survey method.
This report is, to the best of our knowledge, the first to
evaluate how anxiety and depression affect sleep quality and the
severity of insomnia. The prevalence of high risk for insomnia
and the comorbidities with anxiety and depression is comparable
to the findings of previous reports. Daytime sleepiness, general
sleep quality, and insomnia severity were consistently poorer
in subjects with both depression and anxiety. Also, we
found that the effect of the combination of both psychiatric
conditions was mediated by general sleep quality indices,
which encompass insomnia and related somatic symptoms.
We surmise that anxiety and depression affect insomnia in
a supra-additive manner. When treating insomnia patients,
clinicians should look for underlying comorbid psychiatric
conditions to determine the appropriate therapy and enhance the
therapeutic effect.
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